Inactief instrument

Andere talen Wuhan General Group (China), Inc. Other OTC

Aandelen

WUHN

US9825691051

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

M2Bio Sciences Pharmacology and Clinical Application of CBD	18-09-23
Institute of Biomedical Research Corp. Appoints Adrian J. Maizey to Advisory Board of M2Bio Sciences	19-07-23
Wuhan General China : Announces Disposal	18-07-22
Institute of Biomedical Research Corp. agreed to acquire Biomedical and Nutraceutical Assets of Wuhan General Group, Inc. (OTCPK : WUHN).	18-07-22
Wuhan General China : Annual disclosure and Financial Statements	30-03-22
Wuhan General Group, Inc. reached an agreement to acquire a 40% stake in Tsime Pharmaceuticals Ltd from Bataung Likate and other shareholders.	08-12-21
Wuhan General (China) : Quarterly Report 30 September 2021	22-11-21
Wuhan General (China) : Quarterly Report 30 September 2021	19-11-21
Wuhan General China : Group, Inc.	21-07-21
Wuhan General Group, Inc. Announces Appointment of Michael Sachar as CEO of M2bio Sciences Food &Beverage	20-05-21
Wuhan General Group, Inc. announced that it expects to receive $0.45 million in funding from ThreeD Capital Inc.	30-12-20
CORRECTING and REPLACING – Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com	22-05-20
Jeff Robinson, CEO of Wuhan, Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com	22-05-20
Wuhan to Launch CBD Cosmetics and CBD Infused Coffee in South Africa	07-11-19
Wuhan to Launch CBD Cosmetics and CBD Infused Coffee in South Africa	07-11-19
Wuhan General Group Appoints Distinguished Scientist Dr. Hyder A. Khoja as Chief Scientific Officer	15-08-19
Wuhan General Group Appoints Hyder A. Khoja as Chief Scientific Officer	15-08-19
Wuhan General Group, Inc. Announces Strategic Reorganization to Capitalize Medical Marijuana and Psilocybin Mushroom Industries; Appoints Luka Marjanovic as Head of Product Development for the MJ MedTech Division in South Africa	07-08-19
Wuhan Provides Updates on Corporate, Psilocybin and Cannabis Q3 2019 Milestones	02-07-19
Wuhan Expands Capacity to Produce Medicinal Marijuana and Mushrooms	17-05-19

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Wuhan General Group (China), Inc. Other OTC

Aandelen

WUHN

US9825691051

Andere talen

Filters